Closed-loop audit of muscle sampling in Trans-Urethral Resection of Bladder Tumour

Abstract

Introduction:

Our experience with the presence of detrusor muscle (DM) following Trans-Urethral Resection of Bladder Tumour (TURBT).

Objectives:

To evaluate the presence of DM in primary TURBT specimens as a quality improvement exercise in Frimley Park Hospital, UK. And to assess if the level of the surgeon has impact on outcomes.

Methods:

Retrospective and prospective analysis of the electronic records from a single urology centre, servicing a group of urologists. Data collected over three consecutive audit loops between January 2014 and May 2018.

Results:

A total of 301 cases were performed under the care of seven consultant urologists. Analysis revealed a significant improvement in the overall quality of resections from 39% to 66% (50–84% for intermediate and high grade) after the introduction of the following interventions: (1) analysis and improved awareness of current practice; (2) introduction of European Association of Urology (EAU) guidelines by separating samples and sending a second specimen pot marked as bladder tumour base to look for DM; (3) dedicated urologists with an interest in bladder cancer performing en-bloc resection technique in appropriate cases.

Conclusion:

Through our closed-loop audits, we have demonstrated a considerable improvement in the quality of resections, resulting in accurate staging from the initial resection. This could in turn lead to improved over all prognoses and negating the need for re-resection in all cases of high-risk non-muscle invasive bladder cancer (NMIBC).

Level of evidence:

Keywords

TURBT bladder cancer closed-loop audit non-muscle invasive bladder cancer detrusor muscle Trans-Urethral Resection of Bladder Tumour

Get full access to this article

View all access options for this article.

References

Herr

HW.

Early history of endoscopic treatment of bladder tumors from Grunfeld’s polypenkneipe to the Stern-McCarthy resectoscope. J Endourol 2006; 20(2): 85–91.

Herr

Donat

SM.

Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102(9, Pt B): 1242–1246.

Dutta

Smith

Jr Shappell

, et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001; 166(2): 490–493.

Woldu

Bagrodia

Lotan

Guideline of guidelines: Non-muscle-invasive bladder cancer. BJU Int 2017; 119: 371–380.

Babjuk

Böhle

Burger

, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017; 71(3): 447–461.

Mariappan

Zachou

Grigor

, et al. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 2010; 57: 843–849.

Shindo

Masumori

Kitamura

, et al. Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: Multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC). World J Urol 2014; 32(5): 1281–1285.

Brausi

Collette

Kurth

, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 2002; 41(5): 523–531.

Gakis

Karl

Bertz

, et al. Transurethral en-bloc hydrodissection for non-muscle invasive bladder cancer: Results of a randomized controlled trial. Eur Urol Suppl 2017; 16: e1143–e1144.

10.

Lin

Chen

, et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor. Medicine 2016; 95(45): e5372.

11.

Yang

Wang

Han

, et al. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: A meta-analysis. Lasers Med Sci 2017; 32(9): 2005–2012.